Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Amgen's Denosumab Turned Down Again, but It May Not Be as Bad as It Seems
BNET Pharma
Friday, October 23, 2009 - 5:26am
tags:
FDA, Amgen, Prolia, denosumab
Novo Nordisk Drug Helps Healthy Lose Weight, Cut Blood Pressure
Bloomberg
Friday, October 23, 2009 - 5:25am
tags:
Novo Nordisk, liraglutide
Sepracor CEO in line for $11M golden handshake
Fierce Biotech
Friday, October 23, 2009 - 5:24am
tags:
Sepracor, M&A, Dainippon Sumitomo
EU OKs Merck/Schering-Plough Merger
TheStreet.com
Friday, October 23, 2009 - 5:23am
tags:
Merck, Schering Plough, Europe, M&A
Cost cuts buoy drug groups’ profits
FT.com
Thursday, October 22, 2009 - 7:49pm
tags:
earnings, Merck, Novartis, Schering Plough, Bristol-Myers Squibb
Genzyme: The Gift That Keeps on Giving
Motley Fool
Thursday, October 22, 2009 - 4:30pm
tags:
Genzyme
Unusual Call Activity in Cephalon: Options
TheStreet.com
Thursday, October 22, 2009 - 4:26pm
tags:
Cephalon, options
Good Luck in 2010, Amgen
Motley Fool
Thursday, October 22, 2009 - 4:24pm
tags:
Amgen, earnings, Enbrel, Prolia
Buy! Sell! More Wheeling, Dealing from Bristol-Myers CEO
WSJ Online
Thursday, October 22, 2009 - 4:20pm
tags:
Bristol-Myers Squibb, Pharma CEOs, M&A, Medarex, Jim Cornelius
Eli Lilly Adds Jobs, Plans Cuts
WSJ Online
Thursday, October 22, 2009 - 4:15pm
tags:
Eli Lilly, layoffs, reorganization
Novartis CEO Says Most U.S. Swine Flu Vaccine Coming Next Year
Bloomberg
Thursday, October 22, 2009 - 4:14pm
tags:
Novartis, H1N1, swine flu, vaccines, Daniel Vasella
Drug stocks wrap around flat line; Amgen falls on drug delay
Marketwatch
Thursday, October 22, 2009 - 4:13pm
tags:
drug stocks, Amgen, FDA
Bio Box: Eli Lilly CEO John Lechleiter
Yahoo/AP
Thursday, October 22, 2009 - 4:11pm
tags:
Pharma CEOs, Eli Lilly, John Lechleiter
Novartis' Tasigna Seen Succeeding Top Drug Gleevec
WSJ Online
Thursday, October 22, 2009 - 9:48am
tags:
Novartis, Tasigna, Gleevac, leukemia
Red Flags in Biotech
In the Pipeline
Thursday, October 22, 2009 - 9:45am
tags:
biotech
C.R. Bard Surpasses Zacks Estimate
Yahoo/Zacks.com
Thursday, October 22, 2009 - 9:43am
tags:
CR Bard, earnings
Mixed data for AZ, BMS diabetes drug in new study
Reuters
Thursday, October 22, 2009 - 9:24am
tags:
Bristol-Myers Squibb, diabetes, AstraZeneca, Dapagliflozin
Earnings Call Is a Requiem for Schering-Plough
WSJ Online
Thursday, October 22, 2009 - 9:21am
tags:
earnings, Schering Plough
Schering-Plough Discriminated Against Some Docs?
Pharmalot
Thursday, October 22, 2009 - 9:19am
tags:
Schering Plough, physician gifts
FDA delays ruling on Acorda's MS drug until Jan. 22
Yahoo/AP
Thursday, October 22, 2009 - 9:13am
tags:
Acorda Therapeutics, FDA, MS, multiple sclerosis, Fampridine-SR

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.